Erythema Chronicum Migrans: Clinical Trials

2 trials for Erythema Chronicum Migrans, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Recruiting 1

Follow Erythema Chronicum Migrans: new trials by email Literature Review of Erythema Chronicum Migrans trials Research Report on Erythema Chronicum Migrans

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Saccharomyces Boulardii CNCM I-745 on Gut Microbiota in Patients Undergoing Antibiotic Therapy (in the Context of Erythema Migrans (Early Skin Form of Lyme Borreliosis))
Amoxicillin + Saccharomyces boulardii CNCM I-745, Amoxicillin + Placebo, Stool samples - Erythema Migrans of Lyme Disease
Phase 4RecruitingBiocodex1202025-07-162025-08-27
Comparing 3 Antibiotic Regimes for Erythema Migrans in General Practice
Doxycycline, Phenoxymethylpenicillin, Amoxicillin - Erythema Migrans, Erythema Chronicum Migrans
Phase 4CompletedMorten Lindbaek2252011-06-012014-12-12

Narrower conditions

Glossitis, Benign Migratory (2)  ·  Lyme Disease (2)  ·  Borrelia Infections (1)

Broader conditions

Bacterial Infections (2)  ·  Bacterial Infections and Mycoses (2)  ·  Erythema (2)  ·  Glossitis (2)  ·  Gram-Negative Bacterial Infections (2)  ·  Infections (2)  ·  Mouth Diseases (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Bacterial (2)  ·  Skin Diseases, Infectious (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Spirochaetales Infections (2)  ·  Stomatognathic Diseases (2)  ·  Tick-Borne Diseases (2)  ·  Tongue Diseases (2)

Interventions

Amoxicillin (2)  ·  Doxycycline (1)  ·  Penicillin V (1)

Sponsors

Biocodex (1)  ·  Morten Lindbaek (1)

Countries

Norway (1)  ·  Slovenia (1)

Top investigators

Morten Lindbak, Professor (1)

Results publications

PMID 29505880

NIH funding

2023 (1)